Literature DB >> 26997581

CrossTalk opposing view: Intramyocellular ceramide accumulation does not modulate insulin resistance.

Max C Petersen1, Michael J Jurczak2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26997581      PMCID： PMC4908018          DOI： 10.1113/JP271677

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  30 in total

1.  Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling.

Authors:  Yonghao Yu; Sang-Oh Yoon; George Poulogiannis; Qian Yang; Xiaoju Max Ma; Judit Villén; Neil Kubica; Gregory R Hoffman; Lewis C Cantley; Steven P Gygi; John Blenis
Journal:  Science       Date:  2011-06-10       Impact factor: 47.728

2.  The sphingosine-1-phosphate analog FTY720 reduces muscle ceramide content and improves glucose tolerance in high fat-fed male mice.

Authors:  Clinton R Bruce; Steve Risis; Joanne R Babb; Christine Yang; Robert S Lee-Young; Darren C Henstridge; Mark A Febbraio
Journal:  Endocrinology       Date:  2012-11-26       Impact factor: 4.736

3.  Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate.

Authors:  C Schmitz-Peiffer; D L Craig; T J Biden
Journal:  J Biol Chem       Date:  1999-08-20       Impact factor: 5.157

4.  Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes.

Authors:  J F Caro; M K Sinha; S M Raju; O Ittoop; W J Pories; E G Flickinger; D Meelheim; G L Dohm
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

5.  Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide.

Authors:  S A Summers; L A Garza; H Zhou; M J Birnbaum
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

6.  Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle.

Authors:  Marek Straczkowski; Irina Kowalska; Agnieszka Nikolajuk; Stella Dzienis-Straczkowska; Ida Kinalska; Marcin Baranowski; Malgorzata Zendzian-Piotrowska; Zofia Brzezinska; Jan Gorski
Journal:  Diabetes       Date:  2004-05       Impact factor: 9.461

7.  Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B.

Authors:  Suzanne Stratford; Kyle L Hoehn; Feng Liu; Scott A Summers
Journal:  J Biol Chem       Date:  2004-06-25       Impact factor: 5.157

8.  Ceramide content is increased in skeletal muscle from obese insulin-resistant humans.

Authors:  John M Adams; Thongchai Pratipanawatr; Rachele Berria; Elaine Wang; Ralph A DeFronzo; M Cameron Sullards; Lawrence J Mandarino
Journal:  Diabetes       Date:  2004-01       Impact factor: 9.461

9.  Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes.

Authors:  M Straczkowski; I Kowalska; M Baranowski; A Nikolajuk; E Otziomek; P Zabielski; A Adamska; A Blachnio; J Gorski; M Gorska
Journal:  Diabetologia       Date:  2007-08-28       Impact factor: 10.122

10.  Mechanisms underlying the onset of oral lipid-induced skeletal muscle insulin resistance in humans.

Authors:  Bettina Nowotny; Lejla Zahiragic; Dorothea Krog; Peter J Nowotny; Christian Herder; Maren Carstensen; Toru Yoshimura; Julia Szendroedi; Esther Phielix; Peter Schadewaldt; Nanette C Schloot; Gerald I Shulman; Michael Roden
Journal:  Diabetes       Date:  2013-03-01       Impact factor: 9.461
View more
  18 in total

1.  Skeletal muscle ceramides and relationship with insulin sensitivity after 2 weeks of simulated sedentary behaviour and recovery in healthy older adults.

Authors:  Paul T Reidy; Alec I McKenzie; Ziad Mahmassani; Vincent R Morrow; Nikol M Yonemura; Paul N Hopkins; Robin L Marcus; Matthew T Rondina; Yu Kuei Lin; Micah J Drummond
Journal:  J Physiol       Date:  2018-10-09       Impact factor: 5.182

Review 2.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

3.  Rebuttal from Max C. Petersen and Michael J. Jurczak.

Authors:  Max C Petersen; Michael J Jurczak
Journal:  J Physiol       Date:  2016-03-20       Impact factor: 5.182

4.  A Role for Ceramides, but Not Sphingomyelins, as Antagonists of Insulin Signaling and Mitochondrial Metabolism in C2C12 Myotubes.

Authors:  Min Park; Vincent Kaddai; Jianhong Ching; Kevin T Fridianto; Ryan J Sieli; Shigeki Sugii; Scott A Summers
Journal:  J Biol Chem       Date:  2016-10-04       Impact factor: 5.157

Review 5.  Sphingolipids and phospholipids in insulin resistance and related metabolic disorders.

Authors:  Peter J Meikle; Scott A Summers
Journal:  Nat Rev Endocrinol       Date:  2016-10-21       Impact factor: 43.330

Review 6.  Cholesterol - the devil you know; ceramide - the devil you don't.

Authors:  Trevor S Tippetts; William L Holland; Scott A Summers
Journal:  Trends Pharmacol Sci       Date:  2021-11-05       Impact factor: 14.819

Review 7.  Contribution of specific ceramides to obesity-associated metabolic diseases.

Authors:  Philipp Hammerschmidt; Jens C Brüning
Journal:  Cell Mol Life Sci       Date:  2022-07-05       Impact factor: 9.207

8.  Sphingolipid changes do not underlie fatty acid-evoked GLUT4 insulin resistance nor inflammation signals in muscle cells.

Authors:  Nicolas J Pillon; Scott Frendo-Cumbo; Maya R Jacobson; Zhi Liu; Paul L Milligan; Hai Hoang Bui; Juleen R Zierath; Philip J Bilan; Joseph T Brozinick; Amira Klip
Journal:  J Lipid Res       Date:  2018-05-23       Impact factor: 5.922

Review 9.  Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Trends Pharmacol Sci       Date:  2017-05-24       Impact factor: 14.819

Review 10.  Ceramides in Metabolism: Key Lipotoxic Players.

Authors:  Bhagirath Chaurasia; Scott A Summers
Journal:  Annu Rev Physiol       Date:  2020-11-06       Impact factor: 19.318
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.